Last reviewed · How we verify

NCT03529305

Effects of rTMS on Brain Alterations in Stroke Patients

Status unknown NA Last updated 7 August 2019
What this trial tests

NA trial testing rTMS in Stroke in 10 participants. Status unknown.

Timeline
1 January 2018
Primary endpoint
31 December 2020
31 December 2020

Quick facts

Lead sponsorHangzhou Normal University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment10
Start date1 January 2018
Primary completion31 December 2020
Estimated completion31 December 2020
Sites2 locations across China

Drugs / interventions tested

Conditions studied

Sponsor

Hangzhou Normal University

Who can join

Adults 40 to 75, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, the investigators aim to evaluate functional and structural improvements in the brain of stroke patients after rTMS treatment using multi-modal MRI techniques. Specifically, the investigators sought to determine whether rTMS treatment modulate the brain function and structure in patients and, if so, whether different frequency of the rTMS treatment will affect the degree of the motor recovery in patients' brain. The patients will be randomized into three groups: Experimental group 1 (TMS group) received low frequency rTMS; Experimental group 2 (TMS group) received high frequency rTMS; The third group who received only physical therapy constituted the control group. All patients undergo MRI scan one day before and after rTMS treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of rTMS

Trials testing the same drug.

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Hangzhou Normal University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03529305.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing